{
    "nct_id": "NCT03828747",
    "title": "A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients With Moderate Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2024-08-29",
    "description_brief": "This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the clinical efficacy, safety, pharmacokinetics, and pharmacodynamics of semorinemab in patients with moderate AD. The study consists of a screening period, a double-blind treatment period, an optional open-label extension (OLE) period, and a safety follow-up period. There may be up to two study cohorts.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "A total of 272 participants were enrolled at 49 centers.",
            "recruitmentDetails": "The study was conducted at 49 centers in 4 countries.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Semorinemab",
                    "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                }
            ],
            "periods": [
                {
                    "title": "Double-Blind Treatment Period",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "136"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "136"
                                }
                            ]
                        },
                        {
                            "type": "Cohort 1",
                            "comment": "Participants who completed the double-blind treatment period (before implementation of Protocol Version 3), or participants who completed the double-blind study drug treatment through Week 45 without any missed doses of study drug (after implementation of Protocol Version 4), were assigned to Cohort 1. In Cohort 1, the double-blind treatment period has a duration of 48 weeks.",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "92"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "99"
                                }
                            ]
                        },
                        {
                            "type": "Cohort 2",
                            "comment": "Participants who were active in the double-blind treatment period (after implementation of Protocol Version 3) or participants who missed one or more study drug dose (after implementation of Protocol version 4) were assigned to Cohort 2. In Cohort 2, the double-blind treatment period has a duration of 60 weeks.",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "43"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "33"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "106"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "102"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "30"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "34"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "6"
                                }
                            ]
                        },
                        {
                            "type": "Death",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "17"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "19"
                                }
                            ]
                        },
                        {
                            "type": "Physician Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "Various reasons",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Open-Label Extension",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "102"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "97"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "48"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "52"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "54"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "45"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "9"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "7"
                                }
                            ]
                        },
                        {
                            "type": "Death",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "31"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "30"
                                }
                            ]
                        },
                        {
                            "type": "Various reasons",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "Physician Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Semorinemab",
                    "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "136"
                        },
                        {
                            "groupId": "BG001",
                            "value": "136"
                        },
                        {
                            "groupId": "BG002",
                            "value": "272"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "Years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "71.6",
                                            "spread": "8.2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "73.0",
                                            "spread": "8.0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "72.3",
                                            "spread": "8.1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "92"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "84"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "176"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "52"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "96"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "7"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "117"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "115"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "232"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "15"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "18"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "33"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "9"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "122"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "119"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "241"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "21"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline to Last Visit of Double-Blind Treatment Period in Cognitive Function as Measured by the Alzheimer's Disease Assessment Scale, Cognitive Subscale, 11-Item Version (ADAS-Cog11)",
                    "description": "The Alzheimer's Disease Assessment Scale, Cognitive Subscale, 11-Item Version (ADAS-Cog11) is an 11 item cognitive subscale used to quantify the areas of cognitive function most often affected in Alzheimer's disease. The total score ranges from 0-70 with lower scores indicating better cognitive function.",
                    "populationDescription": "The modified intent-to-treat population included all randomized participants who received at least one dose of study drug and had at least one baseline and one postbaseline ADAS-Cog11 score.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "123"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "115"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "123"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "115"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "23.93",
                                            "spread": "0.533"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.09",
                                            "spread": "0.589"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 49 (includes Cohort 1 and 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "102"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "96"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.96",
                                            "spread": "0.658"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "6.85",
                                            "spread": "0.643"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 61 (only Cohort 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "38"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "30"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.71",
                                            "spread": "0.907"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "8.47",
                                            "spread": "0.965"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 49",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.0008",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "-2.89",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-4.56",
                            "ciUpperLimit": "-1.21",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.849"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 61",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.0351",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "-2.75",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-5.31",
                            "ciUpperLimit": "-0.20",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.287"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline to Last Visit of Double-Blind Treatment Period in Functional Capacities as Measured by the Alzheimer's Disease Cooperative Study-Daily Living Inventory (ADCS-ADL)",
                    "description": "The Alzheimer's Disease Cooperative Study-Daily Living Inventory (ADCS-ADL) is a scale used to quantify performance of activities of daily living (ADL). Scores on the ADCS-ADL range from 0-78, with higher scores indicating better ADL function.",
                    "populationDescription": "The modified intent-to-treat population included all randomized participants who received at least one dose of study drug and had at least one baseline and one postbaseline ADAS-Cog11 and the ADCS-ADL score at the given time point.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "123"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "115"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "123"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "115"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "62.03",
                                            "spread": "0.764"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "59.74",
                                            "spread": "0.842"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 49 (includes Cohort 1 and 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "107"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "101"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-7.63",
                                            "spread": "1.002"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-6.80",
                                            "spread": "0.974"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 61 (only Cohort 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "33"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-9.29",
                                            "spread": "1.343"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-7.57",
                                            "spread": "1.462"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 49",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.5207",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "-0.83",
                            "ciPctValue": "95",
                            "ciLowerLimit": "-3.39",
                            "ciUpperLimit": "1.72",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.295"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 61",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3704",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "-1.72",
                            "ciPctValue": "95",
                            "ciLowerLimit": "-5.50",
                            "ciUpperLimit": "2.07",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.911"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline to Last Visit of Double-Blind Treatment Period on the Clinical Dementia Rating-Sum of Boxes (CDR-SB)",
                    "description": "The Clinical Dementia Rating-Sum of Boxes (CDR-SB) is a scale used to quantify the severity of symptoms of dementia. The CDR-SB is obtained through interviews of patients and informants, and disease severity is rated in 6 domains of functioning: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Each domain is rated on a 5-point scale of functioning as follows: 0, no impairment; 0.5, questionable impairment; 1, mild impairment; 2, moderate impairment; and 3, severe impairment (personal care is scored on a 4-point scale without a 0.5 rating available). The CDR-SB score is obtained by summing each of the domain box scores, with scores ranging from 0 to 18, with the higher values representing more severe impairment.",
                    "populationDescription": "The modified intent-to-treat population included all randomized participants who received at least one dose of study drug and had at least one baseline and one postbaseline ADAS-Cog11 and the CDR-SB score at the given time point.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "123"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "115"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "123"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "115"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.23",
                                            "spread": "0.156"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "6.51",
                                            "spread": "0.182"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 49 (includes Cohort 1 and 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "109"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "101"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.80",
                                            "spread": "0.217"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.54",
                                            "spread": "0.214"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 61 (only Cohort 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "33"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.45",
                                            "spread": "0.367"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.28",
                                            "spread": "0.393"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 49",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3501",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "0.26",
                            "ciPctValue": "95",
                            "ciLowerLimit": "-0.29",
                            "ciUpperLimit": "0.82",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.282"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 61",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.7431",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "0.17",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.87",
                            "ciUpperLimit": "1.22",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.525"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline to Last Visit of Double-Blind Treatment Period on the Mini-Mental State Examination (MMSE)",
                    "description": "The Mini Mental State Examination (MMSE) is a brief clinical cognitive examination commonly used to screen for dementia and other cognitive deficits that has a total score of 0-30. Higher scores indicate better cognitive function.",
                    "populationDescription": "The modified intent-to-treat population included all randomized participants who received at least one dose of study drug and had at least one baseline and one postbaseline ADAS-Cog11 and the MMSE score at the given time point.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "123"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "115"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "123"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "115"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "18.38",
                                            "spread": "0.182"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "18.15",
                                            "spread": "0.197"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 49 (includes Cohort 1 and 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "105"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "97"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.86",
                                            "spread": "0.330"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-3.12",
                                            "spread": "0.325"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Change from Baseline at Week 61 (only Cohort 2)",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "39"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "29"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.14",
                                            "spread": "0.429"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-4.22",
                                            "spread": "0.466"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 49",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.5366",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "0.27",
                            "ciPctValue": "95",
                            "ciLowerLimit": "-0.58",
                            "ciUpperLimit": "1.11",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.429"
                        },
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "Change from Baseline at Week 61",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.0851",
                            "statisticalMethod": "Mixed Models Analysis",
                            "paramType": "Least Squares Mean Difference",
                            "paramValue": "1.08",
                            "ciPctValue": "95",
                            "ciLowerLimit": "-0.15",
                            "ciUpperLimit": "2.30",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.618"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Percentage of Participants With Adverse Events",
                    "description": "An Adverse Event is any untoward medical occurrence in a subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with the treatment. An adverse event can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding, for example), symptom, or disease temporally associated with the use of a pharmaceutical product, whether or not considered related to the pharmaceutical product. Preexisting conditions which worsen during a study are also considered as adverse events.",
                    "populationDescription": "The safety population included all randomized participants who received at least one dose of either semorinemab or placebo.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline up to end of study (approximately 4 years and 7 months)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        },
                        {
                            "id": "OG002",
                            "title": "Semorinemab (Open-label Extension)",
                            "description": "Semorinemab was administered intravenously in the optional open-label extension period."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "199"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "112"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "107"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "170"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Serum Concentration of RO7105705 at Specified Timepoints",
                    "populationDescription": "The pharmacokinetic(PK)-evaluable population included all safety-evaluable participants with at least 1 post-dose serum PK sample",
                    "reportingStatus": "POSTED",
                    "paramType": "GEOMETRIC_MEAN",
                    "dispersionType": "Geometric Coefficient of Variation",
                    "unitOfMeasure": "Microgram per milliliter (\u00b5g/ml)",
                    "timeFrame": "Weeks 1,3,5,9,13,25,37,49, and at treatment discontinuation (up to Week 48) for Cohort 1. Weeks 1,3,5,9,13,25,37,49,61, and at treatment discontinuation (up to Week 60) for Cohort 2.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "0"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Week 1 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "130"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "spread": "NA",
                                            "comment": "NA = not reportable as study drug hadn't been administered yet."
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 1 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "129"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1610",
                                            "spread": "27.9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 3 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "127"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "546",
                                            "spread": "32.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 3 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "128"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1980",
                                            "spread": "32.6"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 5 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "127"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "951",
                                            "spread": "30.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 5 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "125"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2260",
                                            "spread": "47.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 9 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "116"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "935",
                                            "spread": "32.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 9 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "117"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2520",
                                            "spread": "27.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 13 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "118"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "943",
                                            "spread": "32.9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 13 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "114"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2480",
                                            "spread": "31.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 25 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "110"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "996",
                                            "spread": "37.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 25 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "108"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2420",
                                            "spread": "37.9"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 37 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "107"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "981",
                                            "spread": "45.4"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 37 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "107"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2430",
                                            "spread": "31.1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 49 predose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "101"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1020",
                                            "spread": "35.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 49 postdose",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "36"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2650",
                                            "spread": "34.2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 61",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "40"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1100",
                                            "spread": "26.8"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Incidence of Anti-drug Antibodies (ADAs) During the Study Relative to the Prevalence of ADAs at Baseline",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Weeks 1,13,25,37,49, and at treatment discontinuation (up to Week 48) for Cohort 1. Weeks 1,13,25,37,49,61, and at treatment discontinuation (up to Week 60) for Cohort 2.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline (BL) - positive sample",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "133"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "129"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "BL - negative sample",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "133"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "129"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "133"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "128"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Post-BL - positive treatment emergent ADA",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "128"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Post-BL - negative treatment emergent ADA",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "128"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "128"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Percentage of Participants With Adverse Events",
                    "description": "Descriptive statistics will be used for assessment.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Up to 57 weeks for Cohort 1, and up to 69 weeks for Cohort 2.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Change From Baseline to Last Visit of Double-Blind Treatment Period in Cognitive Function as Measured by the Alzheimer's Disease Assessment Scale, Cognitive Subscale, 11-Item Version (ADAS-Cog11)",
                    "description": "Descriptive statistics will be used for assessment.\n\nA 70-point scale used to quantify the areas of cognitive function most often affected in Alzheimer's disease. Lower scores indicate better cognitive function.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Change From Baseline to Last Visit of Double-Blind Treatment Period in Functional Capacities as Measured by the Alzheimer's Disease Cooperative Study-Daily Living Inventory (ADCS-ADL)",
                    "description": "Descriptive statistics will be used for assessment.\n\nA scale used to quantify performance of activities of daily living. Scores on the ADCS-ADL range from 0-78, with higher scores indicating better ADL function.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Change From Baseline to Last Visit of Double-Blind Treatment Period on the Clinical Dementia Rating-Sum of Boxes (CDR-SB)",
                    "description": "Descriptive statistics will be used for assessment.\n\nA scale used to quantify the severity of symptoms of dementia. The CDR-SB is obtained through interviews of patients and informants, and disease severity is rated in 6 domains of functioning: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Each domain is rated on a 5-point scale of functioning as follows: 0, no impairment; 0.5, questionable impairment; 1, mild impairment; 2, moderate impairment; and 3, severe impairment (personal care is scored on a 4-point scale without a 0.5 rating available). The CDR-SOB score is obtained by summing each of the domain box scores, with scores ranging from 0 to 18, with the higher values representing more severe impairment.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Change From Baseline to Last Visit of Double-Blind Treatment Period on the Mini-Mental State Examination (MMSE)",
                    "description": "Descriptive statistics will be used for assessment.\n\nThe Mini Mental State Examination (MMSE) is a brief clinical cognitive examination commonly used to screen for dementia and other cognitive deficits that has a total score of 0-30. Higher scores indicate better cognitive function.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to Week 49 for Cohorts 1 and 2, and Baseline to Week 61 for Cohort 2",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Serum Concentration of RO7105705 at Specified Timepoints",
                    "description": "Descriptive statistics will be used for assessment.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Weeks 1,13,25,37,49, and at treatment discontinuation (up to Week 48) for Cohort 1. Weeks 1,13,25,37,49,61, and at treatment discontinuation (up to Week 60) for Cohort 2.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Relationship Between ADA Status and Incidence of Anti-Drug Antibodies (ADAs) During the Study Relative to the Prevalence of ADAs at Baseline",
                    "description": "Descriptive statistics will be used for assessment.",
                    "populationDescription": "Participants with at least one predose and one postdose ADA assessment were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Weeks 1,13,25,37,49, and at treatment discontinuation (up to Week 48) for Cohort 1. Weeks 1,13,25,37,49,61, and at treatment discontinuation (up to Week 60) for Cohort 2.",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Semorinemab",
                            "description": "Semorinemab was administered intravenously in the double-blind treatment period and was administered intravenously in the optional open-label extension period."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "135"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "132"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Positive Sample at BL",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Positive Sample post BL",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "NA",
                                            "comment": "Since there were no participants with ADAs, this relationship is not possible to establish."
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Baseline up to end of study (approximately 4 years and 7 months)",
            "description": "The safety population included all randomized participants who received at least one dose of either semorinemab or placebo.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Semorinemab (Double Blind)",
                    "description": "Semorinemab was administered intravenously in the double-blind treatment period",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 135,
                    "seriousNumAffected": 23,
                    "seriousNumAtRisk": 135,
                    "otherNumAffected": 78,
                    "otherNumAtRisk": 135
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "Placebo was administered intravenously in the double-blind treatment period and semorinemab was administered intravenously in the optional open-label extension.",
                    "deathsNumAffected": 3,
                    "deathsNumAtRisk": 132,
                    "seriousNumAffected": 22,
                    "seriousNumAtRisk": 132,
                    "otherNumAffected": 74,
                    "otherNumAtRisk": 132
                },
                {
                    "id": "EG002",
                    "title": "Semorinemab (OLE)",
                    "description": "Semorinemab was administered intravenously in the optional open-label extension period.",
                    "deathsNumAffected": 2,
                    "deathsNumAtRisk": 199,
                    "seriousNumAffected": 37,
                    "seriousNumAtRisk": 199,
                    "otherNumAffected": 122,
                    "otherNumAtRisk": 199
                }
            ],
            "seriousEvents": [
                {
                    "term": "Leukocytosis",
                    "organSystem": "Blood and lymphatic system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Atrial fibrillation",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cardiac failure",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Stress cardiomyopathy",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Abdominal pain",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Colitis",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hernial eventration",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Inguinal hernia strangulated",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Death",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Non-cardiac chest pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cholelithiasis",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "COVID-19",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cystitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Gastroenteritis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Urosepsis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Craniocerebral injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Femoral neck fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Head injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hip fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Joint dislocation",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Patella fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "SARS-CoV-2 test positive",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Dehydration",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Diabetic metabolic decompensation",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Adenocarcinoma metastatic",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Invasive ductal breast carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Ovarian cancer",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Renal neoplasm",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Squamous cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Transitional cell carcinoma recurrent",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cerebrovascular accident",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Dysarthria",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Seizure",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Subarachnoid haemorrhage",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Upper motor neurone lesion",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hydronephrosis",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Nephrolithiasis",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Renal failure",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Pulmonary embolism",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Aortic aneurysm",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Peripheral artery thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Arrhythmia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Sinus node dysfunction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cholecystitis",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "COVID-19 pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Aggression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Peripheral artery aneurysm",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Intestinal obstruction",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Asthenia",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hypothermia",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Biliary fistula",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Epididymitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Escherichia bacteraemia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Sepsis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Brain contusion",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cervical vertebral fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Femur fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Rib fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Lung cancer metastatic",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Lung neoplasm malignant",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Cerebellar infarction",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Generalised tonic-clonic seizure",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Loss of consciousness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Anuria",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Prostatitis",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Scrotal oedema",
                    "organSystem": "Reproductive system and breast disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Deep vein thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 199
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 7,
                            "numAffected": 7,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 6,
                            "numAffected": 5,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 10,
                            "numAffected": 10,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Nasopharyngitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 10,
                            "numAffected": 9,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 14,
                            "numAffected": 11,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 19,
                            "numAffected": 16,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 36,
                            "numAffected": 27,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 20,
                            "numAffected": 14,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 28,
                            "numAffected": 19,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 64,
                            "numAffected": 37,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Infusion related reaction",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 30,
                            "numAffected": 14,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 9,
                            "numAffected": 5,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 16,
                            "numAffected": 14,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Arthralgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 8,
                            "numAffected": 8,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 12,
                            "numAffected": 11,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 8,
                            "numAffected": 8,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 11,
                            "numAffected": 9,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 8,
                            "numAffected": 7,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 14,
                            "numAffected": 11,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 10,
                            "numAffected": 9,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 13,
                            "numAffected": 10,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 8,
                            "numAffected": 8,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 8,
                            "numAffected": 8,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 19,
                            "numAffected": 18,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Anxiety",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 11,
                            "numAffected": 9,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 12,
                            "numAffected": 12,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 11,
                            "numAffected": 11,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Depression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 11,
                            "numAffected": 10,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 7,
                            "numAffected": 7,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 6,
                            "numAffected": 6,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Insomnia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 7,
                            "numAffected": 7,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 13,
                            "numAffected": 13,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "Hypertension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 10,
                            "numAffected": 8,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 199
                        }
                    ]
                },
                {
                    "term": "COVID-19",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 26.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 135
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 132
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 36,
                            "numAffected": 36,
                            "numAtRisk": 199
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
            },
            "pointOfContact": {
                "title": "Medical Communications",
                "organization": "Hoffmann-La Roche",
                "email": "genentech@druginfo.com",
                "phone": "800-821-8590"
            }
        }
    },
    "target_category": "Disease-targeted biologic",
    "drug": [
        "Semorinemab (MTAU9937A; RO7105705)"
    ],
    "placebo": [
        "Placebo"
    ],
    "explanation_target": [
        "Reason: The investigational product semorinemab (also listed as MTAU9937A / RO7105705) is a humanized monoclonal antibody that targets tau protein \u2014 i.e., a biologic aimed at an Alzheimer\u2019s disease pathology (tau). This indicates a disease-targeted biologic approach rather than a symptomatic/cognitive-only therapy. \ue200cite\ue202turn0search2\ue202turn0search1\ue201",
        "Act (key extracted details): Trial NCT03828747/MTAU9937A is a Phase II, randomized, double-blind, placebo-controlled study of semorinemab in moderate AD. Semorinemab is described in preclinical and early clinical reports as an anti-tau IgG4 monoclonal antibody that binds all six human tau isoforms and shows target engagement. The trial entry lists semorinemab (MTAU9937A/RO7105705) as the active drug and placebo as control. \ue200cite\ue202turn0search1\ue202turn0search2\ue202turn0search8\ue201",
        "Reflect: Classification check \u2014 because semorinemab is an antibody directed at tau pathology (intended to modify disease-related pathology/spread), it fits the definition of a \"disease-targeted biologic.\" Note: Phase II results have been mixed (some signals in certain endpoints/cohorts reported and other trials failed to meet primary endpoints), and clinical development status has evolved; these outcome details do not change the mechanism-of-action classification but are relevant context. \ue200cite\ue202turn0search7\ue202turn0search5\ue202turn0search12\ue201"
    ],
    "agent_type": "B) Tau",
    "explanation_agent": [
        "Reason: The investigational product semorinemab (MTAU9937A / RO7105705; semorinemab) is a humanized IgG4 monoclonal antibody that binds the N\u2011terminal domain of tau and was developed to bind full\u2011length, phosphorylated and oligomeric tau species and to slow cell\u2011to\u2011cell spread of tau pathology \u2014 i.e., the intervention directly targets tau pathology rather than symptomatic neurotransmitter systems. \ue200cite\ue202turn0search8\ue202turn0search7\ue201",
        "Act: Key extracted details from the trial description and literature: the Phase II Lauriet study (NCT03828747) tested semorinemab in mild\u2011to\u2011moderate AD (MTAU9937A listed as the investigational drug); semorinemab is described as an anti\u2011tau monoclonal antibody that binds all six human tau isoforms (N\u2011terminal epitope, residues ~6\u201323) and shows target engagement in humans and preclinical models. These facts identify the biological focus as tau-directed immunotherapy. \ue200cite\ue202turn0search4\ue202turn0search8\ue202turn0search6\ue201",
        "Reflect: Semorinemab\u2019s mechanism (anti\u2011tau passive immunotherapy) maps directly to CADRO category B) Tau. The intervention is a disease\u2011targeted biologic aimed at modulating tau pathology rather than a symptomatic, multi\u2011target, or non\u2011therapeutic procedure, so the most specific CADRO assignment is B) Tau. (Noted that clinical outcomes have been mixed/negative on some endpoints, but this does not change the mechanism\u2011of\u2011action classification.) \ue200cite\ue202turn0search8\ue202turn0search2\ue201",
        "Web search results used (selected): Lauriet Phase II publication and full text describing semorinemab and study details. \ue200cite\ue202turn0search8\ue201",
        "Preclinical and phase\u20111 characterization of semorinemab (IgG4 anti\u2011tau that binds all six isoforms). \ue200cite\ue202turn0search7\ue201",
        "Clinical trial registration and study description for NCT03828747 (semorinemab / MTAU9937A). \ue200cite\ue202turn0search4\ue201",
        "Company description / press and Alzforum therapeutic summary describing target and mechanism. \ue200cite\ue202turn0search1\ue202turn0search6\ue201"
    ]
}